描 述：MART-1 (26-35) has been shown to be better recognized by a number of polyclonal and monoclonal populations of tumor-reactive HLA-A*0201-restricted cytotoxic T lymphocytes (CTL) than MART-1 (27-35) (human).许多肿瘤反应性HLA-A*0201限制性细胞毒性T淋巴细胞(CTL)的多克隆和单克隆群体对MART-1(26-35)的识别能力强于MART-1(27-35)(人)。
